What a joke, nothing on stopping the neuronal cascade of death.
Overview
| Author(s)/Faculty: Edward C. Jauch, MD, MS, FAHA, FACEP; Andy S. Jagoda, MD, FACEP; Philip B. Gorelick, MD, MPH, FACP; Lee H. Schwamm, MD, FAHA | |
| Source: Healio - Cardiology Education Lab | |
| Type: Multimedia | Articles/Items: 6 |
| Release Date: 12/11/2015 | Expiration Date: 12/11/2016 |
| Credit Type: CME | Number of Credits: 1.5 |
| Cost: Free | Provider:  |
According
to the American Heart Association, strokes are experienced by
approximately 795,000 Americans each year and remain the leading cause
of disability in North America. It is important for emergency room
physicians to identify and treat patients with acute ischemic stroke
(AIS) quickly in order to best retain patients’ quality of life.
Treatment of AIS is time sensitive, and with the recent updates to the
use of endovascular procedures and thrombolytic therapy, physicians need
to be prepared for a shift in the treatment paradigm without
compromising patient safety. In this activity, leading neurologists and
emergency medicine physicians discuss the latest evidence and
recommendations on stroke management, including updates to guidelines on
thrombolytic use, new data concerning endovascular procedures, and
information on how the use of telemedicine and collaboration between
stroke systems of care can improve processes and patient outcomes.Test Yourself » | |
CME Information
Provider Statement: This continuing medical education activity is provided by 
.
Support Statement: This activity is supported by an educational grant from Genentech, Inc.
Target Audience: The intended audience for the activity is emergency department physicians, nurses, and other health care professionals involved in the treatment of patients with acute ischemic stroke (AIS).
Learning Objective: Upon successful completion of the activities, participants should be better able to:
Edward C. Jauch, MD, MS, FAHA, FACEP
Division Director and Professor
Department of Medicine, Division of Emergency Medicine
Professor, Department of Neurosciences
Associate Vice Chair, Research, Department of Medicine
Medical University of South Carolina
Charleston, SC
Faculty:
Andy S. Jagoda, MD, FACEP
Professor and System Chair
Department of Emergency Medicine
Icahn School of Medicine at Mount Sinai
New York, NY
Philip B. Gorelick, MD, MPH, FACP
Professor
Translational Science and Molecular Medicine
Michigan State University
Medical Director
Mercy Health Hauenstein Neurosciences
Mercy Health Physician Partners
Grand Rapids, MI
Lee H. Schwamm, MD, FAHA
Vice Chairman, Department of Neurology
C. Miller Fisher Endowed Chair
Director
MGH Stroke Services
Massachusetts General Hospital
Professor of Neurology
Harvard Medical School
Cambridge, MA
Peer Reviewer:
Kama Z. Guluma, M.D.
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Approved by the American College of Emergency Physicians for a maximum of 1.50 hour(s) of ACEP Category I credit.
For the purpose of recertifying with American Nurses Credentialing Center (ANCC), AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME can be used.
This enduring material is approved for 1 year from the date of original release, December 11, 2015 through December 11, 2016.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must watch the presentation, and complete the CME posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 out of 4 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Activity Chair and Faculty Members report the following relationship(s):
Edward C. Jauch, MD, MS, FAHA, FACEP
Executive Committee: Covidien Ltd., Genentech, Inc., Penumbra, Inc., Stryker
Andy S. Jagoda, MD, FACEP
Served as an advisor or consultant for: Banyan Biomarkers, Janssen, Pfizer, Teva
Executive board: Ferne
Philip B. Gorelick, MD, MPH, FACP
Served as an advisor or consultant for (paid to institution): Novartis
Served as a speaker or a member of a speakers bureau for (paid to institution): Boehringer Ingelheim, Pfizer
Lee H. Schwamm, MD, FAHA
Received grants for clinical research from: Genentech, National Institute of Neurological Disorders and Stroke
Target: Stroke Working Group, Chair Stroke Clinical Work Group
Steering & Science Committee: American Heart Association
Steering Committee: Lundbeck, Medtronic
Data Safety and Monitoring Board: Penumbra
Peer Reviewer reports the following relationship(s):
Kama Z. Guluma, M.D.
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2015 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at CME@VindicoCME.com
.Support Statement: This activity is supported by an educational grant from Genentech, Inc.
Target Audience: The intended audience for the activity is emergency department physicians, nurses, and other health care professionals involved in the treatment of patients with acute ischemic stroke (AIS).
Learning Objective: Upon successful completion of the activities, participants should be better able to:
- Utilize evidence-based inclusion and exclusion criteria to determine candidates for thrombolytic therapy in AIS.
- Incorporate strategies that decrease delays in door-to-needle time in patients with AIS.
- Integrate established guidelines, recommendations, and clinical study findings to enable the safe and effective use of thrombolysis in patients who present with AIS.
- Compare the safety and efficacy of the various reperfusion strategies.
- Evaluate the current use of telemedicine within stroke systems of care and the importance of coordinating care within the transferring facilities to improve patient outcomes.
Edward C. Jauch, MD, MS, FAHA, FACEP
Division Director and Professor
Department of Medicine, Division of Emergency Medicine
Professor, Department of Neurosciences
Associate Vice Chair, Research, Department of Medicine
Medical University of South Carolina
Charleston, SC
Faculty:
Andy S. Jagoda, MD, FACEP
Professor and System Chair
Department of Emergency Medicine
Icahn School of Medicine at Mount Sinai
New York, NY
Philip B. Gorelick, MD, MPH, FACP
Professor
Translational Science and Molecular Medicine
Michigan State University
Medical Director
Mercy Health Hauenstein Neurosciences
Mercy Health Physician Partners
Grand Rapids, MI
Lee H. Schwamm, MD, FAHA
Vice Chairman, Department of Neurology
C. Miller Fisher Endowed Chair
Director
MGH Stroke Services
Massachusetts General Hospital
Professor of Neurology
Harvard Medical School
Cambridge, MA
Peer Reviewer:
Kama Z. Guluma, M.D.
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Approved by the American College of Emergency Physicians for a maximum of 1.50 hour(s) of ACEP Category I credit.
For the purpose of recertifying with American Nurses Credentialing Center (ANCC), AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME can be used.
This enduring material is approved for 1 year from the date of original release, December 11, 2015 through December 11, 2016.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must watch the presentation, and complete the CME posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 out of 4 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Activity Chair and Faculty Members report the following relationship(s):
Edward C. Jauch, MD, MS, FAHA, FACEP
Executive Committee: Covidien Ltd., Genentech, Inc., Penumbra, Inc., Stryker
Andy S. Jagoda, MD, FACEP
Served as an advisor or consultant for: Banyan Biomarkers, Janssen, Pfizer, Teva
Executive board: Ferne
Philip B. Gorelick, MD, MPH, FACP
Served as an advisor or consultant for (paid to institution): Novartis
Served as a speaker or a member of a speakers bureau for (paid to institution): Boehringer Ingelheim, Pfizer
Lee H. Schwamm, MD, FAHA
Received grants for clinical research from: Genentech, National Institute of Neurological Disorders and Stroke
Target: Stroke Working Group, Chair Stroke Clinical Work Group
Steering & Science Committee: American Heart Association
Steering Committee: Lundbeck, Medtronic
Data Safety and Monitoring Board: Penumbra
Peer Reviewer reports the following relationship(s):
Kama Z. Guluma, M.D.
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2015 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at CME@VindicoCME.com
No comments:
Post a Comment